Skip to main content
无锡晶海 logo

无锡晶海 — Investor Relations & Filings

Ticker · 920547 Beijing Stock Exchange Manufacturing
Open in API
Filings indexed 300 across all filing types
Latest filing 2025-07-06 Board/Management Inform…
Country CN China
Listing Beijing Stock Exchange 920547

About 无锡晶海

https://www.chinaaminoacid.com/

Wuxi Jinghai Amino Acid Co., Ltd. specializes in the research, development, and large-scale production of high-purity amino acids through microbial fermentation. The company’s core product portfolio includes L-Isoleucine, L-Valine, L-Leucine, L-Proline, and L-Threonine, which serve as critical raw materials for the pharmaceutical, nutritional, and food processing sectors. Utilizing advanced biotechnological processes, the firm maintains rigorous quality control standards, holding certifications such as GMP, ISO, HALAL, and KOSHER. Its products are primarily utilized in the formulation of parenteral nutrition, specialized medical foods, and high-end supplements. The company focuses on technological innovation to optimize fermentation yields and purity levels, positioning itself as a key supplier in the global amino acid supply chain.

Recent filings

Filing Released Lang Actions
证券事务代表任命公告
Board/Management Information Classification · 100% confidence The document is an announcement regarding the appointment of a securities affairs representative (a type of senior management role) at Wuxi Jinghai Amino Acid Co., Ltd. It details the appointment decision made by the board, the qualifications of the appointee, and compliance with relevant laws. There is no financial data, no report attached or referenced as being published, and no mention of voting results or other report types. This fits the category of Board/Management Information (MANG), which covers announcements of changes in senior management.
2025-07-06 Chinese
关于设立新加坡全资子公司并完成工商注册登记的公告
Capital/Financing Update Classification · 95% confidence The document is an official announcement by Wuxi Jinghai Amino Acid Co., Ltd. regarding the establishment of a wholly-owned subsidiary in Singapore and related overseas investment plans. It includes details about the investment amount, purpose, risk factors, and approvals required. The document explicitly states it is an announcement (公告) about the investment and company registration, not a financial report or detailed financial statements. The length is about 3,098 characters, which is relatively short and consistent with an announcement rather than a full report. There is no financial data or comprehensive financial analysis presented, so it is not an Annual Report (10-K), Interim Report (IR), or Earnings Release (ER). It is also not a regulatory certification or officer attestation. The content fits best with a Capital/Financing Update (CAP) as it concerns company fundraising and capital structure changes through establishing new subsidiaries and investment activities overseas. Therefore, the correct classification is CAP with high confidence.
2025-06-24 Chinese
2024年年度权益分派实施公告
Notice of Dividend Amount Classification · 100% confidence The document is an announcement regarding the implementation of the 2024 annual equity distribution (dividend) plan of Wuxi Jinghai Amino Acid Co., Ltd. It details the dividend amount, payment method, record date, and tax treatment for shareholders. It references the shareholders' meeting approval but does not contain financial statements or detailed financial performance data. The document is short (1198 characters) and focuses on dividend distribution specifics, which aligns with a Notice of Dividend Amount filing rather than an annual report or earnings release. Therefore, the appropriate classification is Notice of Dividend Amount (DIV).
2025-05-25 Chinese
无锡晶海氨基酸股份有限公司2024年年度股东会法律意见书
Regulatory Filings
2025-05-08 Chinese
投资者关系活动记录表
Investor Presentation Classification · 95% confidence The document is titled as an "投资者关系活动记录表" which translates to "Investor Relations Activity Record." It specifically mentions a "业绩说明会" which means "Performance Explanation Meeting" or "Earnings Presentation." The content includes a Q&A session discussing the company's 2024 annual report results and future outlook, typical of an earnings or performance explanation meeting. The document length is short (1332 characters) and it records the investor relations event rather than providing full financial statements or detailed financial data. This matches the characteristics of an Investor Presentation (IP) rather than a full Annual Report (10-K) or Earnings Release (ER). Therefore, the document is best classified as an Investor Presentation (IP).
2025-05-08 Chinese
2024年年度股东会决议
Declaration of Voting Results & Voting Rights Announcements Classification · 95% confidence The document is titled as a 2024 Annual General Meeting (AGM) resolution announcement for Wuxi Jinghai Amino Acid Co., Ltd. It details the meeting date, attendance, agenda items, and voting results on various proposals including approval of the 2024 annual report, board and supervisory reports, financial statements, dividend distribution plan, and remuneration plans. The document also references that the full 2024 annual report and other detailed disclosures were previously published on April 18, 2025, on the Beijing Stock Exchange information platform. The document itself is a formal announcement of the AGM resolutions and voting outcomes, not the full annual report or financial statements. It is over 5,000 characters and contains detailed voting results and meeting procedural information. Therefore, it fits the category of Declaration of Voting Results & Voting Rights Announcements (DVA).
2025-05-08 Chinese

Browse filings by year

4 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.